Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Vaccine

• Publication date

  2009-09-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2009.07.037PMID 19647814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1

  2007cited by this paper
• Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.

  2007cited by this paper
• Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal Immunization

  2007cited by this paper
• Activation of NF-κB by the intracellular expression of NF-κB-inducing kinase acts as a powerful vaccine adjuvant

  2006cited by this paper
• Modified Pulmonary Surfactant Is a Potent Adjuvant That Stimulates the Mucosal IgA Production in Response to the Influenza Virus Antigen1

  2006cited by this paper
• Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.

  2006cited by this paper
• In vitro enzymatic degradation of nanoparticles prepared from hydrophobically-modified poly(gamma-glutamic acid).

  2005cited by this paper
• Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier.

  2005cited by this paper
• Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection

  2005cited by this paper
• The Streptococcus pyogenes Capsule Is Required for Adhesion of Bacteria to Virus-Infected Alveolar Epithelial Cells and Lethal Bacterial-Viral Superinfection

  2004cited by this paper
• Current status of live attenuated influenza virus vaccine in the US.

  2004cited by this paper
• Vaccination with formalin-inactivated influenza vaccine protects mice against lethal influenza Streptococcus pyogenes superinfection.

  2004cited by this paper
• Influenza A Virus-Infected Hosts Boost an Invasive Type of Streptococcus pyogenes Infection in Mice

  2003cited by this paper
• Mucosal Immunization with Virus-Like Particles of Simian Immunodeficiency Virus Conjugated with Cholera Toxin Subunit B

  2003cited by this paper
• The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines.

  2003cited by this paper
• Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

  2002cited by this paper
• Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

  2001cited by this paper
• Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response

  2001cited by this paper
• Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.

  1998cited by this paper
• Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.

  1998cited by this paper
• Musosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: Induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen

  1998cited by this paper
• Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.

  1996cited by this paper
• Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

  1994cited by this paper
• Superior cross‐protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

  1992cited by this paper
• Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.

  1990cited by this paper
• Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza.

  1990cited by this paper
• Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine.

  1989cited by this paper
• Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit.

  1988cited by this paper
• Enterotoxigenic Escherichia coli diarrhea in an endemic area prepares the intestine for an anamnestic immunoglobulin A antitoxin response to oral cholera B subunit vaccination

  1988cited by this paper
• Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

  1984cited by this paper
• Immunity to influenza in man.

  1983cited by this paper
• Pathogenicity of influenza virus

  1980cited by this paper

• Microbially derived (γ-PGA) poly-γ-glutamic acid: applications and commercial uses across industries.

  2025cites this paper
• Niosomes as a vehicle for excretory/secretory antigens enhance immunization efficacy of Toxoplasma gondii vaccine.

  2025cites this paper
• The Role of Macrophages in Airway Disease Focusing on Porcine Reproductive and Respiratory Syndrome Virus and the Treatment with Antioxidant Nanoparticles

  2024cites this paper
• Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses

  2023cites this paper
• Harnessing sortase A transpeptidation for advanced targeted therapeutics and vaccine engineering.

  2023cites this paper
• Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination.

  2023cites this paper
• Use of Nanomaterials for Diagnosis and Treatment: The Advancement of Next-Generation Antiviral Therapy

  2022cites this paper
• Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy

  2022cites this paper
• Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID)

  2021cites this paper
• Enhancing Immune Responses to a DNA Vaccine Encoding Toxoplasma gondii GRA7 Using Calcium Phosphate Nanoparticles as an Adjuvant

  2021influential citation
• Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses

  2021cites this paper
• Poly(glutamic acid): Production, composites, and medical applications of the next-generation biopolymer

  2021cites this paper
• Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives

  2021cites this paper
• Environmental aspect and applications of nanotechnology to eliminate COVID-19 epidemiology risk

  2021cites this paper
• Biomaterials-based formulations and surfaces to combat viral infectious diseases

  2021cites this paper
• Smart and Sustainable Nanotechnological Solutions in a Battle against COVID-19 and Beyond: A Critical Review

  2021cites this paper
• Nanoparticles development for pulmonary vaccination: Challenges and opportunities

  2021cites this paper
• Insight into Nanomedicinal Approaches to Combat Viral Zoonoses.

  2020cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• Nanotechnologies: A Key Role in Virus Fight

  2020cites this paper
• Nanoparticles for mucosal vaccine delivery

  2020cites this paper
• Nanomaterials and Nanotechnology-Associated Innovations against Viral Infections with a Focus on Coronaviruses

  2020cites this paper
• On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges

  2020cites this paper
• Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

  2019cites this paper
• Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections

  2019cites this paper
• Application of some nanoparticles in the field of veterinary medicine

  2019cites this paper
• Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.

  2019cites this paper
• Food Additives as Novel Influenza Vaccine Adjuvants

  2019cites this paper
• Comprehensive evaluation of chitosan nanoparticle based phage lysin delivery system; a novel approach to counter S. pneumoniae infections.

  2019cites this paper
• Nanoparticle-Based Vaccines Against Respiratory Viruses

  2019cites this paper
• Development of analytical methods for evaluating the quality of dissociated and associated amphiphilic poly(γ-glutamic acid) nanoparticles

  2018cites this paper
• Advanced applications of nanotechnology in veterinary medicine

  2018cites this paper
• Characterization and analytical development for amphiphilic poly(γ-glutamic acid) as raw material of nanoparticle adjuvants.

  2018cites this paper
• Overview of Polyester Nanosystems for Nasal Administration

  2017cites this paper
• Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine

  2017cites this paper
• Polymeric Nanoparticles for Vaccine Delivery

  2017cites this paper
• Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate

  2017cites this paper
• Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.

  2017cites this paper
• Characteristics of novel polymer based on pseudo-polyamino acids GluLa-DPG-PEG600: binding of albumin, biocompatibility, biodistribution and potential crossing the blood-brain barrier in rats

  2017cites this paper
• Polymers in Nanomedicine - ReadingSample

  2017cites this paper
• Intranasal delivery of nanoparticle-based vaccines.

  2017cites this paper
• Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.

  2017cites this paper
• Nanomedicine and Infection

  2016cites this paper
• Raspberry-like poly(γ-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs

  2016cites this paper
• Antibiotic Drug Delivery Systems for the Intracellular Targeting of Bacterial Pathogens

  2016cites this paper
• Evaluating the Interactions Between Proteins and Components of the Immune System with Polymer Nanoparticles

  2016cites this paper
• articleToll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats

  2015cites this paper
• Recent advances in developing vaccines against Toxoplasma gondii: an update

  2015cites this paper
• Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection.

  2015cites this paper
• Intranasal administration of poly-gamma glutamate induced antiviral activity and protective immune responses against H1N1 influenza A virus infection

  2015cites this paper
• Near‐Industrialization Nanotechnologies Developed in JST's Nanomanufacturing Research Area in Japan

  2015cites this paper
• Cross-reactivity of immunoglobulin A secreted on the nasal mucosa in mice nasally inoculated with inactivated H1N1 influenza A viruses in the presence of D-octaarginine-linked polymers.

  2015cites this paper
• Engineered Cell Manipulation for Biomedical Application

  2014cites this paper
• Amphiphilic γ-PGA nanoparticles administered on rat middle ear mucosa produce adjuvant-like immunostimulation in vivo

  2014influential citation
• Proteins and Poly(Amino Acids)

  2014cites this paper
• Functional Nanoparticles for Vaccine Delivery Systems

  2014cites this paper
• Uptake of biodegradable poly(γ-glutamic acid) nanoparticles and antigen presentation by dendritic cells in vivo.

  2013cites this paper
• Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine

  2013cites this paper
• Polymeric nanogels as vaccine delivery systems.

  2013cites this paper
• An MDCK Cell Culture-Derived Formalin-Inactivated Influenza Virus Whole-Virion Vaccine from an Influenza Virus Library Confers Cross-Protective Immunity by Intranasal Administration in Mice

  2013cites this paper
• Differentiation of induced pluripotent stem cells toward neurons in hydrogel biomaterials.

  2013cites this paper
• [Study of next generation influenza vaccine focused on "cross-protection by mucosal immunization" and "seed virus strains"].

  2013cites this paper
• Chemical Modification of Microbial Poly(γ-glutamic acid)

  2013cites this paper
• Comparison of the Cross-Reactive Anti-Influenza Neutralizing Activity of Polymeric and Monomeric IgA Monoclonal Antibodies

  2012cites this paper
• Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.

  2012cites this paper
• Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection

  2012cites this paper
• Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.

  2012cites this paper
• Nanotechnology developments: opportunities for animal health and production

  2012cites this paper
• Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.

  2012cites this paper
• Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine

  2011cites this paper
• Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity

  2011cites this paper
• Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).

  2011cites this paper
• Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids.

  2011cites this paper
• Current major cancer targets for nanoparticle systems.

  2011cites this paper
• A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus.

  2011cites this paper
• Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles.

  2011cites this paper
• Synthesis and high performance of magnetofluorescent polyelectrolyte nanocomposites as MR/near-infrared multimodal cellular imaging nanoprobes.

  2011cites this paper
• Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes.

  2011cites this paper
• Biomedical Applications of Biodegradable Polymers.

  2011cites this paper
• Selection of Adjuvants for Enhanced Vaccine Potency

  2011cites this paper
• Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.

  2011cites this paper
• Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice.

  2011cites this paper
• The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.

  2011cites this paper
• Silver nano - a trove for retinal therapies.

  2010cites this paper
• Evaluation of the immune response and protective effects of rhesus macaques vaccinated with biodegradable nanoparticles carrying gp120 of human immunodeficiency virus.

  2010cites this paper
• Pharmaceutical and Medical Applications of Poly-Gamma-Glutamic Acid

  2010cites this paper
• Research paths to successful prevention and treatment of swine-derived H1N1 influenza virus infection.

  2010cites this paper
• Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats

  2010cites this paper
• Nieuwe influenza A (H1N1) - Mexicaanse griep

  2009cites this paper